Resources

Biosimilars in the Pharmacy Benefit

Published 07/03/2020

Despite the fact that less than 2% of the US population uses biologic drugs, they account for 26% of national prescription drug spending. Biosimilars can expand options, enhance affordability, and increase access to therapy. It’s been estimated that biosimilars could save patients and the healthcare system from $54 to $250 billion over their first 10...

Cannabis Products on the Formulary

Published 07/03/2020

As access to cannabis expands via state-level legalization, employers must address a variety of challenges resulting from employee cannabis use. Most notably, employers need to confront workplace accommodation issues, workplace safety challenges, and coverage decisions. These issues are complicated by the fact that possessing cannabis and aiding and abetting the possession of cannabis remain illegal...

Local and National Data Available on Return to Work Strategies

Published 05/18/2020

The RIBGH would like to thank all those who participated in the National Alliance of Healthcare Purchaser Coalition's national Pulse of the Purchaser Poll - COVID-19 Return to Work Strategies. Data from a total of 210 employers, ranging in size and industry, was successfully collected. The results provided a rich insight into what employers are...

Action Brief: Covid-19 The Importance of Shared Decision Making

Published 04/22/2020

Source: The National Alliance of Healthcare Purchaser Coalitions | added 04/22/20 Helping employees make informed decisions about their choices and responsibilities is a growing trend that is especially important in light of COVID-19. Having a tool to guide shared decision-making conversations enables employees to think through their questions and concerns in advance of an office or e-visit so conversations with healthcare providers are efficient...

Understanding The Spread of Covid-19

Published 04/22/2020

Source: The National Alliance of Healthcare Purchaser Coalitions | added 04/22/20 As corporations are beginning to deal with the COVID-19 pandemic, the practical aspects of how to take action are becoming more challenging. To appreciate the implications, let’s look at an example if an employee is found to be ill with COVID-19.